Scandion Oncology Investor Relations Material
Latest events
Q4 2023
Scandion Oncology
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Scandion Oncology
Access all reports
Scandion Oncology A/S is a clinical-stage biotechnology company, which focuses on developing medicines for the treatment of chemotherapy resistance. Scandion Oncology A/S was founded in 2017 and is headquartered in Copenhagen, Denmark.
Key slides for Scandion Oncology
Q2 2023
Scandion Oncology
Q3 2023
Scandion Oncology
Latest articles
Remembering Daniel Kahneman: Transforming Psychology and Economics
Explore Daniel Kahneman's legacy in psychology and economics, highlighting his impact on decision-making and behavioral economics.
28 Mar 2024
Deere & Company: Shaping Agriculture & Construction Since 1837
Exploring Deere & Company: A global leader in agriculture & construction equipment since 1837.
28 Mar 2024
Jane Fraser: First Female Leader of a Major Wall Street Bank
Discover the journey of Jane Fraser, CEO of Citigroup and the first female leader of a major Wall Street bank.
28 Mar 2024
Ticker symbol
Country
🇸🇪 Sweden